ClinicalTrials.gov
public full text
Public Domain
Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis
To demonstrate the safety of 1% OPA-15406 ointment in adult patients with AD and of 0.3% and 1% OPA-15406 ointments in pediatric patients with AD administered twice daily for 52 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis#828069
- Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis#912874
- Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome#968556
- A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects#1058282
- Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis#1031012
Record · ID 1137892
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive